{
 "PrintNo":"A3820","Version":"A","Session":2019,"Chamber":"ASSEMBLY","BillType":"Assembly",
 "Published":"2019-01-31T10:55:52.805834Z","Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2020-01-08","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2019-01-31","Chamber":"ASSEMBLY"},
  {"Text":"AMEND (T) AND RECOMMIT TO HEALTH","Date":"2019-12-30","Chamber":"ASSEMBLY"},
  {"Text":"PRINT NUMBER 3820A","Date":"2019-12-30","Chamber":"ASSEMBLY","Version":"A"},
  {"Text":"REFERRED TO HEALTH","Date":"2020-01-08","Chamber":"ASSEMBLY","Version":"A"}
 ],
 "Sponsors":[
  {"ID":662,"Name":"John T. McDonald III","Short":"MCDONALD"},{"ID":504,"Name":"Felix Ortiz","Short":"ORTIZ"},
  {"ID":476,"Name":"Michael Montesano","Short":"MONTESANO"},{"ID":636,"Name":"Christopher Friend","Short":"FRIEND"},
  {"ID":546,"Name":"Ellen C. Jaffee","Short":"JAFFEE"},{"ID":1120,"Name":"Billy Jones","Short":"JONES"},
  {"ID":493,"Name":"Charles Barron","Short":"BARRON"},{"ID":576,"Name":"Donna Lupardo","Short":"LUPARDO"},
  {"ID":1130,"Name":"Anthony D'Urso","Short":"D'URSO"},{"ID":1133,"Name":"Monica P. Wallace","Short":"WALLACE"},
  {"ID":906,"Name":"Rebecca Seawright","Short":"SEAWRIGHT"},
  {"ID":670,"Name":"Angelo Santabarbara","Short":"SANTABARBARA"},{"ID":675,"Name":"Phil Steck","Short":"STECK"},
  {"ID":621,"Name":"Sandy Galef","Short":"GALEF"},{"ID":657,"Name":"Patricia Fahy","Short":"FAHY"},
  {"ID":551,"Name":"Kevin Cahill","Short":"CAHILL"},{"ID":631,"Name":"Kenneth Blankenbush","Short":"BLANKENBUSH"}
 ],
 "Title":"Limits the initial prescription of a controlled substance for the alleviation of acute pain",
 "Summary":"Limits the initial prescription of a controlled substance for the alleviation of acute pain to a seven-day supply for users twenty years of age or older and to a three-day supply for users nineteen years of age or younger.",
 "LawSection":"Public Health Law","LawCode":"Amd ยง3331, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to limiting the initial prescription of a controlled substance for the alleviation of acute pain to a seven-day supply for users twenty years of age or older and to a three-day supply for users nineteen years of age or younger",
 "SameAsPrintNo":"S2053-2019","PreviousVersions":["A7741-2017"]
}